MEI Pharma (MEIP) News Today $6.72 -0.01 (-0.15%) (As of 12/8/2023 ET) Add Compare Share Share Today's Range$6.56▼$6.8850-Day Range$5.66▼$7.8452-Week Range$4.00▼$7.97Volume35,000 shsAverage Volume82,188 shsMarket Capitalization$44.76 millionP/E Ratio1.08Dividend YieldN/APrice Target$24.50 HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMEI Pharma (NASDAQ:MEIP) Now Covered by StockNews.comamericanbankingnews.com - December 3 at 1:22 AMStifel Nicolaus Reaffirms Their Hold Rating on MEI Pharma (MEIP)markets.businessinsider.com - November 16 at 6:44 AMMEI Pharma Inc MEIPmorningstar.com - November 14 at 9:06 PMMEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlightsfinance.yahoo.com - November 9 at 7:06 PMMEI Pharma to Present at the Stifel 2023 Healthcare Conferencefinance.yahoo.com - November 8 at 9:45 AMMEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stockfinance.yahoo.com - November 6 at 9:00 PMMEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023finance.yahoo.com - November 2 at 9:44 AMMEI Pharma Enters into Agreement with Anson Funds and Cable Car Capitalfinance.yahoo.com - November 1 at 1:49 PMMEI Pharma Recommends Stockholders Not to Consentfinance.yahoo.com - October 17 at 6:56 PMAstraZeneca's (AZN) Tagrisso Combo Gets FDA's Priority Reviewfinance.yahoo.com - October 17 at 1:55 PMEditas (EDIT) Gets FDA's RMAT Tag for Gene Therapy to Treat SCDfinance.yahoo.com - October 17 at 1:55 PMCatalyst (CPRX) Seeks to Increase Maximum Daily Dose for Firdapsefinance.yahoo.com - October 16 at 3:12 PMMEI Pharma Adopts Limited-Duration Stockholder Rights Planfinance.yahoo.com - October 2 at 8:47 AMAll You Need to Know About MEI Pharma, Inc. (MEIP) Rating Upgrade to Strong Buyfinance.yahoo.com - September 29 at 3:49 PMMEI Pharma Issues Statement Regarding Anson and Cable Car's Opportunistic Actionsstockhouse.com - September 28 at 5:43 PMMEI Pharma Issues Statement Regarding Anson and Cable Car’s Opportunistic Actionsfinance.yahoo.com - September 28 at 5:43 PMMEI Pharma, Inc. (NASDAQ:MEIP) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - September 27 at 10:21 AMQ4 2023 MEI Pharma Inc Earnings Callfinance.yahoo.com - September 27 at 10:21 AMAnson And Cable Car Send Letter to MEI Pharma Stockholdersfinance.yahoo.com - September 26 at 6:13 PMMEI Pharma Reports Fiscal Year 2023 Results and Operational Highlightsfinance.yahoo.com - September 26 at 6:13 PMAnson Funds Management LP Acquires Shares in MEI Pharma Incfinance.yahoo.com - September 26 at 1:13 PMEarnings Outlook For MEI Pharmabenzinga.com - September 25 at 2:52 PMAnson Funds Management LP Acquires Additional Shares in MEI Pharma Incfinance.yahoo.com - September 23 at 9:45 AMMEI Pharma to Report 2023 Fiscal Year End Financial Results and Provide Corporate Overview on September 26, 2023finance.yahoo.com - September 21 at 10:16 AMSTOCKHOLDER ALERT: Abbott Cooper PLLC Announces Investigation Into Possible Violations of Fiduciary Duty by the Board of Mei Pharma, Inc.markets.businessinsider.com - September 18 at 3:44 PMCORRECTION: Abbott Cooper PLLC Announces Investigation Into Possible Violations of Fiduciary Duty by the Board of Mei Pharma, Inc.markets.businessinsider.com - September 18 at 3:44 PMMEI Pharma Confirms Receipt of Director Nominations From Anson and Cable Carfinance.yahoo.com - September 18 at 10:44 AMMEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVASTIN®) in Patients with Previously Treated Metastatic Colorectal Cancerfinance.yahoo.com - August 16 at 12:30 PMCambridge biotech cuts most staffers after merger falls apartbizjournals.com - July 26 at 4:10 PMAnson and Cable Car Respond to MEI Pharma’s Self-Serving Attempt to Prohibit Stockholders From Removing Directorsfinance.yahoo.com - July 19 at 1:39 PMMEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transactionfinance.yahoo.com - July 19 at 8:38 AMAnson and Cable Car File Preliminary Consent Materials to Remove Entire Board of Directors at MEI Pharma, Inc.finance.yahoo.com - July 17 at 1:34 PMMEI Pharma Encourages Shareholders to Vote FOR the Infinity Transactionfinance.yahoo.com - July 17 at 8:34 AMMEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticalsfinance.yahoo.com - July 11 at 8:24 AMMEI Pharma (MEIP) Price Target Increased by 30.95% to 37.40msn.com - July 6 at 8:33 PMMEI Pharma Responds to Anson and Cable Carfinance.yahoo.com - June 27 at 6:46 PMAnson Funds and Cable Car Capital Issue Statement Regarding the Inferior Proposed Transaction between MEI Pharma and Infinity Pharmaceuticalsfinance.yahoo.com - June 27 at 1:46 PMMEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidatesfinance.yahoo.com - June 15 at 11:46 AMMEI Pharma Hires Justin File As CFO To Succeed Brian Drazbamarkets.businessinsider.com - June 13 at 9:39 AMMEI Pharma CFO to leave, successor hiredmsn.com - June 13 at 9:39 AMMEI Pharma Announces Planned Departure of Chief Financial Officer Brian Drazba and Appointment of Justin File as Successorfinance.yahoo.com - June 13 at 9:39 AMStifel Nicolaus Sticks to Its Hold Rating for MEI Pharma (MEIP)markets.businessinsider.com - June 6 at 10:46 PMMEI Pharma Promotes COO David Urso To Succeed Daniel Gold As President And CEOmarkets.businessinsider.com - June 2 at 1:35 PMMEI Pharma CEO Daniel Gold Stepping Downmarketwatch.com - June 2 at 8:34 AMMEI Pharma Announces Planned Departure of CEO Daniel P. Gold, Ph.D. and Appointment of David M. Urso as Successorfinance.yahoo.com - June 2 at 8:34 AMAnson Funds and Cable Car Capital Issue Statement Regarding MEI Pharma's Rejection of Their Acquisition Proposalbenzinga.com - June 1 at 10:33 PMSpurned MEI Pharma private suitors call rejection 'derogation of fiduciary duties'msn.com - June 1 at 5:33 PMAnson Funds and Cable Car Capital Issue Statement Regarding MEI Pharma’s Rejection of Their Acquisition Proposalfinance.yahoo.com - June 1 at 5:33 PMMEI Pharma Confirms Receipt of Unsolicited Acquisition Proposalfinance.yahoo.com - May 30 at 6:33 PMStifel Nicolaus Remains a Hold on MEI Pharma (MEIP)markets.businessinsider.com - May 29 at 10:31 PM Get MEI Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for MEIP and its competitors with MarketBeat's FREE daily newsletter. Email Address MEIP Media Mentions By Week MEIP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MEIP News Sentiment▼0.000.53▲Average Medical News Sentiment MEIP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MEIP Articles This Week▼01▲MEIP Articles Average Week Get MEI Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for MEIP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CytoMed Therapeutics News Societal CDMO News HCW Biologics News Minerva Neurosciences News ImmunoPrecise Antibodies News Rain Oncology News Hookipa Pharma News Celularity News Lantern Pharma News FibroGen News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:MEIP) was last updated on 12/10/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MEI Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.